GFACX
Price
$74.18
Change
-$1.66 (-2.19%)
Updated
Nov 13 closing price
Net Assets
340.4B
RPXIX
Price
$31.62
Change
-$0.58 (-1.80%)
Updated
Nov 13 closing price
Net Assets
51.49M
Interact to see
Advertisement

GFACX vs RPXIX

Header iconGFACX vs RPXIX Comparison
Open Charts GFACX vs RPXIXBanner chart's image
American Funds Growth Fund of Amer C
Price$74.18
Change-$1.66 (-2.19%)
VolumeN/A
Net Assets340.4B
RiverPark Large Growth Institutional
Price$31.62
Change-$0.58 (-1.80%)
VolumeN/A
Net Assets51.49M
GFACX vs RPXIX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. RPXIX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Buy and RPXIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 340B vs. RPXIX (51.5M). GFACX (0.00) and RPXIX (0.00) have matching dividends . GFACX was incepted earlier than RPXIX: GFACX (25 years) vs RPXIX (15 years). GFACX (1.36) is less costly to investors than RPXIX (1.02). GFACX is a more actively managed with annual turnover of: 25.00 vs. RPXIX (21.00). GFACX has a lower initial minimum investment than RPXIX: GFACX (250) vs RPXIX (50000). RPXIX annual gain was more profitable for investors over the last year : 5.26 vs. GFACX (4.61). GFACX return over 5 years is better than : 27.87 vs. RPXIX (4.83).
GFACXRPXIXGFACX / RPXIX
Total Expense Ratio1.361.00136%
Annual Report Gross Expense Ratio1.361.02133%
Fund Existence25 years15 years-
Gain YTD16.34314.387114%
Front LoadN/AN/A-
Min. Initial Investment250500001%
Min. Initial Investment IRAN/AN/A-
Net Assets340B51.5M660,194%
Annual Yield % from dividends0.000.00-
Returns for 1 year4.615.2688%
Returns for 3 years56.1782.4568%
Returns for 5 years27.874.83578%
Returns for 10 years75.7879.5595%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAX18.70N/A
N/A
Baxter International
OFG40.72-0.03
-0.07%
OFG Bancorp
CVGW21.90-0.23
-1.04%
Calavo Growers
FBIOP6.53-0.27
-3.97%
Fortress Biotech
ACRV2.07-0.21
-9.21%
Acrivon Therapeutics